All the Drug Class Drugs
Meningococcal Vaccine, Toxoid Conjugate Vaccine. Meningococcal Serogroup A 0.4 mcg / 0.5 ml, Meningococcal Serogroup C 0.4 mcg / 0.5 ml, Meningococcal Serogroup Y 0.4 mcg / 0.5 ml, Meningococcal Serogroup W135 0.4 mcg / 0.5 ml. VIAL (Sol. for IM Inj.): 1,5×0.5 ml. Admin. as a 0.5 mL dose by IM inj.
Do not admin. this product IV or S.C.
Primary Vaccination: In child. 9 through 23 mnths. of age, the vaccine is given as a 2-dose series three mnths. apart.
Individuals 2 through 55 yrs. of age- given as a single dose.
Booster Vaccination: A single booster dose may be given to individuals 15 through 55 yrs. of age at continued risk for meningococc. dis., if at least 4 yrs. have elapsed since the prior dose.
Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, is indicated for active immunization to prevent invasive meningococ. dis. caused by Neisseria meningitidis serogroups A, C, Y and W-135. This vaccine is approved for use in individuals 9 mnths. through 55 yrs. of age and does not prevent N meningitides serogroup B dis.
C/I: Sev. allergic react. (eg, anaphylaxis) after a previous dose of a mening. capsular polysaccharide, diphtheria toxoid- or CRM197-contain. vaccine.
